OLINK HOLDING AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.84 USD | -1.00% |
|
+4.44% | -9.18% |
| Apr. 11 | Metacon Appoints New Finance Chief | MT |
| Mar. 25 | Olink Swings to Q4 Net Loss, Revenue Rises | MT |
ETFs positioned on Olink Holding AB
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.15% | 5 M€ | -1.80% | - | |
| 0.12% | 0 M€ | 0.00% | - | |
| 0.10% | 5 M€ | +8.63% | ||
| 0.06% | 0 M€ | 0.00% | - |
Olink Holding AB (publ) is a Sweden-based company engaged in the marketing and sales of biotechnological products and services. The Company offers a technique to identify actionable biomarkers, with a focus on the human plasma proteome. The Company operates in Sweden and the USA.
Sector
Office Equipment
Calendar
2024-05-08
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
22.84
USD
Average target price
26
USD
Spread / Average Target
+13.84%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -9.18% | 2.84B | |
| +7.13% | 7.91B | |
| -3.15% | 4.66B | |
| +1.11% | 2.03B | |
| -26.56% | 1.12B | |
| -11.09% | 816M | |
| -22.71% | 759M | |
| -13.49% | 755M | |
| -56.85% | 682M | |
| -24.66% | 671M |
- Stock Market
- Equities
- OLK Stock
- Funds and ETFs Olink Holding AB
